StartUp Health January 18, 2022

Maze Therapeutics brought in $190M this week; other large rounds went to Verana Health ($150M) and Medically Home ($110M).

Our team tracked more than $670M in health innovation funding reported this week, led by Maze Therapeutics, a South San Francisco, CA-based company translating genetic insights into new precision medicines. The $190M round was led by Matrix Capital Management, with participation from General Catalyst, a16z Bio+Health, Woodline Partners, Casdin Capital, City Hill Ventures, Foresite Capital, Driehaus Capital Management, Moore Strategic Ventures, Terra Magnum Capital Partners, NS Investments, and others. source>

Other recent deals included:

Verana Health, a San Francisco, CA-based digital health company that delivers drug lifecycle and medical practice insights from a real-world data network, raised $150M led by Johnson...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Pharma / Biotech, Precision Medicine, Technology, Trends
New AI drug discovery powerhouse Xaira rises with $1B in funding
Women's virtual care clinic Midi Health raises $60M
AI-enabled drug discovery company Xaira launches with $1B
Claims operation AI company Alaffia Health raises $10M in series A round
Dear venture capitalists: You're blowing it

Share This Article